(1997). Renal disease and acid-suppressing drugs. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/(sici)1099-1557(199707)6:4<247::aid-pds296>3.0.co;2-o.
(1997). The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs. Br J Clin Pharmacol..
(1996). A cohort study of the ocular safety of anti-ulcer drugs. Br J Clin Pharmacol..
(1995). Ocular safety of antiulcer drugs. Lancet..
(1999). One-year follow-up of newly diagnosed irritable bowel syndrome patients. Aliment Pharmacol Ther..
(1999). Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol..
(1998). Comparison of mortality from peptic ulcer bleed between patients with or without peptic ulcer antecedents. Epidemiology..
(2000). Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol..
(2000). Overall mortality among patients surviving an episode of peptic ulcer bleeding. J Epidemiol Community Health..
(2001). Gender and drug treatment as determinants of mortality in a cohort of heart failure patients. Eur J Epidemiol..